Risk Factors for CKD in Persons With Kidney Stones: A Case-Control Study in Olmsted County, Minnesota

American Journal of Kidney Diseases

Volumn 55, Issue 1, 2010, Pages 61-68

  Saucier, Nathan A ^a   Sinha, Mukesh K ^a   Liang, Kelly V ^a,b   Krambeck, Amy E ^a   Weaver, Amy L ^a   Bergstralh, Eric J ^a   Li, Xujian ^a   Rule, Andrew D ^a   Lieske, John C ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

chronic kidney disease; kidney stone; Nephrolithiasis

Indexed keywords

ALLOPURINOL; CITRIC ACID; STRUVITE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PREDICTOR VARIABLE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; URINARY TRACT INFECTION;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY CALCULI; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MINNESOTA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 71849085182     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.08.008     Document Type: Article

References (28)

1. Stamatelou K.K., Francis M.E., Jones C.A., Nyberg L.M., and Curhan G.C. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63 (2003) 1817-1823
2. Saigal C.S., Joyce G., and Timilsina A.R. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?. Kidney Int 68 (2005) 1808-1814
3. Vupputuri S., Soucie J.M., McClellan W., and Sandler D.P. History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14 (2004) 222-228
4. Rule A.D., Bergstralh E.J., Melton III L.J., Li X., Weaver A.L., and Lieske J.C. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4 (2009) 804-811
5. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
6. Collins A.J., Kasiske B., Herzog C., et al. Excerpts from the United States Renal Data System 2004 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 45 1 suppl 1 (2005) A5-A7 S1-280
7. Teichman J.M., Long R.D., and Hulbert J.C. Long-term renal fate and prognosis after staghorn calculus management. J Urol 153 (1995) 1403-1407
8. Griffith D.P. Struvite stones. Kidney Int 13 (1978) 372-382
9. Jungers P., Joly D., Barbey F., Choukroun G., and Daudon M. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44 (2004) 799-805
10. Marangella M., Bruno M., Cosseddu D., et al. Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron 54 (1990) 302-306
11. Worcester E., Parks J.H., Josephson M.A., Thisted R.A., and Coe F.L. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64 (2003) 2204-2213
12. Melton III L.J. History of the Rochester Epidemiology Project. Mayo Clin Proc 71 (1996) 266-274
13. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
14. Rule A.D., and Larson T.S. Do we need another equation to estimate GFR from serum creatinine in renal allograft recipients?. [letter]. Nephrol Dial Transplant 23 (2008) 2427-2428 author reply, 2428
15. Bergstralh E.J., Kosanke J.L., and Jacobsen S.J. Software for optimal matching in observational studies. Epidemiology 7 3 (1996) 331-332
16. Hsu C.Y., McCulloch C.E., Darbinian J., Go A.S., and Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165 (2005) 923-928
17. Borghi L., Meschi T., Guerra A., et al. Essential arterial hypertension and stone disease. Kidney Int 55 (1999) 2397-2406
18. Wexler B.C., and McMurtry J.P. Kidney and bladder calculi in spontaneously hypertensive rats. Br J Exp Pathol 62 (1981) 369-374
19. Lieske J.C., de la Vega L.S., Gettman M.T., et al. Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis 48 (2006) 897-904
20. Gillen D.L., Worcester E.M., and Coe F.L. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67 (2005) 685-690
21. Monk R.D. Clinical approach to adults. Semin Nephrol 16 (1996) 375-388
22. Coe F.L., Evan A., and Worcester E. Kidney stone disease. J Clin Invest 115 (2005) 2598-2608
23. Silva J.M., Diniz J.S., Silva A.C., Azevedo M.V., Pimenta M.R., and Oliveira E.A. Predictive factors of chronic kidney disease in severe vesicoureteral reflux. Pediatr Nephrol 21 (2006) 1285-1292
24. Madersbacher S., Schmidt J., Eberle J.M., et al. Long-term outcome of ileal conduit diversion. J Urol 169 (2003) 985-990
25. Williams C.M., and Thomas Jr. W.C. Permanently decreased renal blood flow and hypertension after lithotripsy. N Engl J Med 321 (1989) 1269-1270
26. Ackaert K.S., and Schroder F.H. Effects of extracorporeal shock wave lithotripsy (ESWL) on renal tissue. A review. Urol Res 17 (1989) 3-7
27. Lingeman J.E., Woods J.R., and Toth P.D. Blood pressure changes following extracorporeal shock wave lithotripsy and other forms of treatment for nephrolithiasis. JAMA 263 (1990) 1789-1794
28. Krambeck A.E., Gettman M.T., Rohlinger A.L., Lohse C.M., Patterson D.E., and Segura J.W. Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. J Urol 175 (2006) 1742-1747